These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 18664715)
41. Collagen gel matrix assay as an in vitro chemosensitivity test for malignant astrocytic tumors. Ono A; Kanno H; Hayashi A; Nishimura S; Kyuma Y; Sato H; Ito S; Shimizu N; Chang CC; Gondo G; Yamamoto I; Sasaki T; Tanaka M Int J Clin Oncol; 2007 Apr; 12(2):125-30. PubMed ID: 17443280 [TBL] [Abstract][Full Text] [Related]
42. The effect of Antineoplaston, a new antitumor agent on malignant brain tumors. Sugita Y; Tsuda H; Maruiwa H; Hirohata M; Shigemori M; Hara H Kurume Med J; 1995; 42(3):133-40. PubMed ID: 7474850 [TBL] [Abstract][Full Text] [Related]
43. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants. Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352 [TBL] [Abstract][Full Text] [Related]
44. [Cytostatic and cytotoxic waste - rules of conduct in Poland]. Furtak-Niczyporuk M; Jaroszyński J; Mela A; Staniszewska A; Piotrowska J; Zimmermann A; Czajka-Bełz A; Dreher P; Dąbrowski J; Kapka-Skrzypczak L Med Pr; 2019 Jun; 70(3):377-391. PubMed ID: 31110397 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of cellular proliferation and induction of apoptosis by curcumin in human malignant astrocytoma cell lines. Nagai S; Kurimoto M; Washiyama K; Hirashima Y; Kumanishi T; Endo S J Neurooncol; 2005 Sep; 74(2):105-11. PubMed ID: 16193380 [TBL] [Abstract][Full Text] [Related]
46. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy. Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873 [TBL] [Abstract][Full Text] [Related]
47. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Lee TD; Lee OW; Brimacombe KR; Chen L; Guha R; Lusvarghi S; Tebase BG; Klumpp-Thomas C; Robey RW; Ambudkar SV; Shen M; Gottesman MM; Hall MD Mol Pharmacol; 2019 Nov; 96(5):629-640. PubMed ID: 31515284 [TBL] [Abstract][Full Text] [Related]
48. [Prospects for the use of plant polysaccharides in complex treatment of malignant tumors]. Safonova EA; Razina TG; Zueva EP; Lopatina KA; Efimova LA; Gur'ev AM; Rybalkina OIu; Khotimchenko IuS Eksp Klin Farmakol; 2012; 75(9):42-7. PubMed ID: 23156088 [TBL] [Abstract][Full Text] [Related]
49. Chemotherapy for malignant brain tumors of astrocytic and oligodendroglial lineage. Hofer S; Herrmann R J Cancer Res Clin Oncol; 2001 Feb; 127(2):91-5. PubMed ID: 11216919 [TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers. Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857 [TBL] [Abstract][Full Text] [Related]
58. Regression of grade III astrocytoma during the treatment of CML with imatinib mesylate. Jayawardena S; Sooriabalan D; Indulkar S; Kim HH; Matin A; Maini A Am J Ther; 2006; 13(5):458-9. PubMed ID: 16988542 [TBL] [Abstract][Full Text] [Related]
59. The inhibitory effect of CIL-102 on the growth of human astrocytoma cells is mediated by the generation of reactive oxygen species and induction of ERK1/2 MAPK. Teng CC; Kuo HC; Cheng HC; Wang TC; Sze CI Toxicol Appl Pharmacol; 2012 Aug; 263(1):73-80. PubMed ID: 22683510 [TBL] [Abstract][Full Text] [Related]
60. Chemotherapy of High-Grade Astrocytomas in Adults. Puduvalli VK; Hoang N Prog Neurol Surg; 2018; 31():116-144. PubMed ID: 29393181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]